Product Description:
The Anti-Human SOST Antibody (AMG 167) is a highly specific and sensitive monoclonal antibody designed to target the Sclerostin protein. Sclerostin is a key regulator of bone metabolism and has been implicated in various bone-related diseases, making it a crucial target for research and therapeutic development.
Biological Function:
The main function of the Anti-Human SOST Antibody is to bind to Sclerostin and inhibit its activity. Sclerostin is known to inhibit bone formation by blocking the Wnt signaling pathway, which is essential for bone growth and maintenance. By blocking Sclerostin, this antibody promotes bone formation and has the potential to improve bone health in individuals with bone disorders.
Main Applications:
This antibody has a wide range of applications in the field of biotechnology and medicine. It can be used in research studies to understand the role of Sclerostin in bone metabolism and to develop new treatments for bone-related diseases such as osteoporosis and osteoarthritis. Additionally, it can also be used in diagnostic tests to measure Sclerostin levels in patients and monitor their response to treatment.
Experimental Use Cases:
The Anti-Human SOST Antibody has shown promising results in pre-clinical studies, demonstrating its potential as a therapeutic agent for bone disorders. In one study, it was found to increase bone mass and strength in mice with osteoporosis, suggesting its potential as a treatment for this condition. In another study, it was shown to improve bone healing in a rat model of osteoporotic fractures.
With its high specificity and sensitivity, this antibody has the potential to revolutionize the treatment of bone disorders and improve the quality of life for millions of people worldwide.
In summary, the Anti-Human SOST Antibody (AMG 167) is a powerful tool for research and therapeutic development in the field of bone biology. Its ability to inhibit Sclerostin and promote bone formation makes it a valuable asset for scientists and clinicians alike. Order now and discover the potential of this antibody in advancing our understanding and treatment of bone-related diseases.
There are no reviews yet.